An in vivo comparison of serum theophylline levels resulting from unco
ated and coated pellets was made using the beagle dog as an animal mod
el. The coated pellets were prepared from an aqueous ethyl cellulose d
ispersion (Aquacoat) in the rotary fluidized bed. A relative bioavaila
bility of 52% was calculated for the coated pellets. The pharmacokinet
ic parameters of theophylline obtained from beagle dog were also deter
mined. A significant correlation coefficient of 0.9584 was calculated
between in vitro percent theophylline release and percent drug absorbe
d in vivo. Finally, it was concluded that the beagle dog model can be
reliably used for the in vivo evaluation of controlled release dosage
forms.